News Regeneron ends development of RSV antibody Regeneron dumps suptavumab after phase 3 trial failure.
News Mundipharma buys rights to CellAct cancer drug Drug will be progressed through phase 3 trials in biliary tract cancer.
News Ionis to file rare disease drug after GSK declines option Firm turns down options for inotersen and IONIS-FB-LRX.
News UK researchers trial new cancer immunotherapy The charity Cancer Research UK has joined with Biotecnol to begin early-stage clinical trials of a new kind of cancer immunotherapy in solid tumours, including lung cancers.
Views & Analysis Challenging antimicrobial drug resistance with calorimetry Tackling antimicrobial drug resistance with calorimetry.
News GW prepares for 2018 US launch of epilepsy drug But Zynerba's cannabis epilepsy drug fails in phase 2.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
